Migraine, hormones and the menopausal transition

References

• Buse DC, Loder EW, Gorman JA, et al. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) study. Headache 2013;53:1278–99
   PubMed Web of Science ®Google Scholar
• Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388:1545–602
   PubMed Web of Science ®Google Scholar
• Ibrahimi K, Couturier EG, MaassenVanDenBrink A. Migraine and perimenopause. Maturitas 2014;78:277–80
   PubMed Web of Science ®Google Scholar
• Van Dijk MG, Kavousi M, Troup J, Franco OH. Health issues for menopausal women: the top 11 conditions have common solutions. Maturitas 2015;80:24–30
   PubMed Web of Science ®Google Scholar
• Vetvik KG, MacGregor EA. Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol 2017;16:76–87
   PubMed Web of Science ®Google Scholar
• Ripa P, Ornello R, Degan D, et al. Migraine in menopausal women: a systematic review. Int J Womens Health 2015;7:773–82
   PubMed Web of Science ®Google Scholar
• MacGregor EA. Perimenopausal migraine in women with vasomotor symptoms. Maturitas 2012;71:79–82
   PubMed Web of Science ®Google Scholar
• MacGregor EA. Migraine, menopause and hormone replacement therapy. Post Reprod Health 2017 Jan 1. [Epub ahead of print]
   PubMedGoogle Scholar
• Pavlovic JM, Akcali D, Bolay H, Bernstein C, Maleki N. Sex-related influences in migraine. J Neurosci Res 2017;95:587–93
   PubMed Web of Science ®Google Scholar
• Spector JT, Kahan SR, Jones MR, Jayakumar M, Dalal D, Nazarian S. Migraine headache and ischemic stroke risk: as updated meta-analysis. Am J Med 2010;123:612–24
   PubMed Web of Science ®Google Scholar
• Linstra KM, Ibrahimi K, Terwindt GM, Wermer MJH, MaassenVanDenBrink A. Migraine and cardiovascular disease in women. Maturitas 2017;97:28–31
   PubMed Web of Science ®Google Scholar
• Bushnell C, McCullough LD, Awad IA, et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014;45:1545–88
   PubMed Web of Science ®Google Scholar
• Spalice A, Del Balzo F, Papetti L, et al. Stroke and migraine is there a possible comorbidity? Ital J Pediatr 2016;42:41
   PubMed Web of Science ®Google Scholar
• Gryglas A, Smigiel R. Migraine and stroke: what's the link? What to do? Curr Neurol Neurosci Rep 2017;17:22
   PubMed Web of Science ®Google Scholar
• Kurth T, Chabriat H, Bousser MG. Migraine and stroke: a complex association with clinical implications. Lancet Neurol 2012;11:92–100
   PubMed Web of Science ®Google Scholar
• Kurth T, Winter AC, Eliassen AH, et al. Migraine and risk of cardiovascular disease in women: prospective cohort study. BMJ 2016;353:2610
   PubMed Web of Science ®Google Scholar
• Hu X, Zhou Y, Zhao H, Peng C. Migraine and the risk of stroke: an updated meta-analysis of prospective cohort studies. Neurol Sci 2017;38:33–40
   PubMed Web of Science ®Google Scholar
• Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edn. Cephalalgia 2013;33:628–808
   Web of Science ®Google Scholar
• Merikangas KR. Contributions of epidemiology to our understanding of migraine. Headache 2013;53:230–46
   PubMed Web of Science ®Google Scholar
• MacGregor EA. Migraine management during menstruation and menopause. Continuum (Minneap Minn) 2015;21:990–1003
   PubMedGoogle Scholar
• Brandes JL. The influence of estrogen on migraine: a systematic review. JAMA 2006;295:1824–30
   PubMed Web of Science ®Google Scholar
• Martin VT, Behbehani M. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis-part I. Headache 2006;46:3–23
   PubMed Web of Science ®Google Scholar
• Chai NC, Peterlin BL, Calhoun AH. Migraine and estrogen. Curr Opin Neurol 2014;27:315–24
   PubMed Web of Science ®Google Scholar
• Pavlovic JM, Allshouse AA, Santoro NF, et al. Sex hormones in women with and without migraine: evidence of migraine-specific hormone profiles. Neurology 2016;87:49–56
   PubMed Web of Science ®Google Scholar
• Martin VT, Behbehani M. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis-part 2. Headache 2006;46:365–86
   PubMed Web of Science ®Google Scholar
• Makita K, Inagaki M, Kitamura S, Tatsuoka Y. Changes in migraine before and after menopause in Japanese climacteric women. Cephalalgia 2017;37:1088–92
   PubMed Web of Science ®Google Scholar
• Güven B, Güven H, Çomoğlu S. Clinical characteristics of menstrually related and non-menstrual migraine. Acta Neurol Belg 2017;117:671–6
   PubMed Web of Science ®Google Scholar
• Magos A. Treatment of menstrual migraine by oestradiol implants. J Neurol Neurosurg Psychiatry 1983;46:1044–6
   PubMed Web of Science ®Google Scholar
• De Lignieres B, Vincens M, Mauvais-Jarvis P, Mas JL, Touboul PJ, Bousser MG. Prevention of menstrual migraine by percutaneous oestradiol. Br Med J (Clin Res Ed) 1986;293:1540
   PubMed Web of Science ®Google Scholar
• Dennerstein L, Morse C, Burrows G, Oats J, Brown J, Smith M. Menstrual migraine: a double-blind trial of percutaneous estradiol. Gynecol Endocrinol 1988;2:113–20
   PubMed Web of Science ®Google Scholar
• Smits MG, van der Meer YG, Pfeil JP, Rijnierse JJ, Vos AJ. Perimenstrual migraine: effect of Estraderm TTS and the value of contingent negative variation and exteroceptive temporalis muscle suppression test. Headache 1994;34:103–6
   PubMed Web of Science ®Google Scholar
• Murray SC, Muse KN. Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and “add-back” therapy. Fertil Steril 1997;67:390–3
   PubMed Web of Science ®Google Scholar
• MacGregor EA, Hackshaw A. Prevention of migraine in the pill-free interval of combined oral contraceptives: a double-blind, placebo-controlled pilot study using natural oestrogen supplements. J Fam Plann Reprod Health Care 2002;28:27–31
   PubMed Web of Science ®Google Scholar
• Martin V, Wernke S, Mandell K, et al. Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache. Headache 2003;43:309–21
   PubMed Web of Science ®Google Scholar
• MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A. Prevention of menstrual attacks of migraine. A double-blind placebo-controlled crossover study. Neurology 2006;67:2159–63
   PubMed Web of Science ®Google Scholar
• Almén-Christensson A, Hammar M, Lindh-Astrand L, Landtblom AM, Brynhildsen J. Prevention of menstrual migraine with perimenstrual transdermal 17-β-estradiol: a randomized, placebo-controlled, double-blind crossover study. Fertil Steril 2011;96:498–500
   PubMed Web of Science ®Google Scholar
• Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972;22:355–65
   PubMed Web of Science ®Google Scholar
• Loder EW, Buse DC, Golub JR. Headache as a side effect of combination estrogen-progestin oral contraceptives: a systematic review. Am J Obstet Gynecol 2005;193:636–49
   PubMed Web of Science ®Google Scholar
• Allais G, Chiarle G, Sinigaglia S, et al. Treating migraine with contraceptives. Neurol Sci 2017;38(Suppl 1):S85–9
   Web of Science ®Google Scholar
• Aegidius K, Zwart JA, Hagen K, Schei B, Stovner LJ. Oral contraceptives and increased headache prevalence. The Head-Hunt Study. Neurology 2006;66:349–53
   PubMed Web of Science ®Google Scholar
• La Guardia KD, Fisher AC, Bainbridge JD, LoCoco JM, Friedman AJ. Suppression of estrogen-withdrawal headache with extended transdermal contraception. Fertil Steril 2005;83:1875–7
   PubMed Web of Science ®Google Scholar
• Sulak P, Willis S, Kuenl T, Coffee A. Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval. Headache 2007;47:27–37
   PubMed Web of Science ®Google Scholar
• Nappi RE, Terreno E, Sances G, et al. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM). Contraception 2013;88:369–75
   PubMed Web of Science ®Google Scholar
• Nappi RE, Merki-Feld GS, Terreno E, Pellegrinelli A, Viana M. Hormonal contraception in women with migraine: is progestogen-only contraception a better choice?. J Headache Pain 2013;14:66–72
   PubMed Web of Science ®Google Scholar
• Nappi RE, Sances G, Allais G, et al. Effects of an estrogen-free, desogestrel-containing oral contraceptive in women with migraine with aura: a prospective diary based pilot study. Contraception 2011;83:223–8
   PubMed Web of Science ®Google Scholar
• Morotti M, Remorgida V, Venturini PL, et al. Progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of pain symptoms caused by endometriosis in patients with migraine without aura. Eur J Obstet Gynecol Reprod Biol 2014;179:63–8
   PubMed Web of Science ®Google Scholar
• Morotti M, Remorgida V, Venturini PL, et al. Progestin-only contraception compared with extended combined oral contraceptive in women with migraine without aura: a retrospective pilot study. Eur J Obstet Gynecol Reprod Biol 2014;183:178–82
   PubMed Web of Science ®Google Scholar
• Vetvik KG, MacGregor EA, Lundqvist C, Russell MB. Contraceptive-induced amenorrhoea leads to reduced migraine frequency in women with menstrual migraine without aura. J Headache Pain 2014;15:30
   PubMed Web of Science ®Google Scholar
• Merki-Feld GS, Imthurn B, Langner R, et al. Positive effects of the progestin desogestrel 75 mg on migraine frequency and use of acute medication are sustained over a treatment period of 180 days. J Headache Pain 2015;16:39–46
   Web of Science ®Google Scholar
• Merki-Feld GS, Imthurn B, Dubey R, Sándor PS, Gantenbein AR. Improvement of migraine with change from combined hormonal contraceptives to progestin-only contraception with desogestrel: how strong is the effect of taking women off combined contraceptives? J Obstet Gynaecol 2017;37:338–41
   PubMedGoogle Scholar
• Warhurst S, Rofe CJ, Brew BJ, et al. Effectiveness of the progestin-only pill for migraine treatment in women: a systematic review and meta-analysis. Cephalalgia 2017 Jan 1. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Sao S, Merki-Feld GS, Aegidius KL, et al. Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). J Headache Pain 2017;18:108
   PubMed Web of Science ®Google Scholar
• Mattsson P. Hormonal factors in migraine: a population-based study of women aged 40 to 74 years. Headache 2003;43:27–35
   PubMed Web of Science ®Google Scholar
• Wang SJ, Fuh JL, Lu SR, Juang KD, Wang PH. Migraine prevalence during menopausal transition. Headache 2003;43:470–8
   PubMed Web of Science ®Google Scholar
• Freeman EW, Sammel MD, Lin H, Gracia CR, Kapoor S. Symptoms in the menopausal transition: hormone and behavioral correlates. Obstet Gynecol 2008;111:127–36
   PubMed Web of Science ®Google Scholar
• Oh K, Jung KY, Choi JY, Seo WK, Park KW. Headaches in middle-aged women during menopausal transition: a headache clinic-based study. Eur Neurol 2012;68:79–83
   PubMed Web of Science ®Google Scholar
• Karli N, Baykan B, Ertaş M, et al. Impact of sex hormonal changes on tension-type headache and migraine: a cross-sectional population-based survey in 2,600 women. J Headache Pain 2012;13:557–65
   PubMed Web of Science ®Google Scholar
• Martin VT, Pavlovic J, Fanning KM, Buse DC, Reed ML, Lipton RB. Perimenopause and menopause are associated with high frequency headache in women with migraine: results of the American Migraine Prevalence and Prevention Study. Headache 2016;56:292–305
   PubMed Web of Science ®Google Scholar
• Sabia S, Fournier A, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F. Risk factors for onset of menopausal symptoms: results from a large cohort study. Maturitas 2008;60:108–21
   PubMed Web of Science ®Google Scholar
• Misakian AL, Langer RD, Bensenor IM, et al. Postmenopausal hormone therapy and migraine headache. J Womens Health (Larchmt) 2003;12:1027–36
   PubMed Web of Science ®Google Scholar
• MacGregor EA. Migraine, the menopause and hormone replacement therapy: a clinical review. J Fam Plann Reprod Health Care 2007;33:245–9
   PubMed Web of Science ®Google Scholar
• Martin VT. Migraine and the menopausal transition. Neurol Sci 2014;35(Suppl 1):S65–9
   PubMed Web of Science ®Google Scholar
• Allais G, Chiarle G, Bergandi F, Benedetto C. Migraine in perimenopausal women. Neurol Sci 2015;36(Suppl 1):S79–83
   PubMed Web of Science ®Google Scholar
• Sturdee DW, Pines A. on behalf of the International Menopause Society Writing Group. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric 2011;14:302–20
   PubMed Web of Science ®Google Scholar
• Position Statement. The 2017 hormone therapy position statement of the North American menopause society. Menopause 2017;24:728–53
   PubMedGoogle Scholar
• MacGregor EA. Migraine headache in perimenopausal and menopausal women. Curr Pain Headache Rep 2009;13:399–403
   PubMed Web of Science ®Google Scholar
• World Health Organization. Medical eligibility criteria for contraceptive use. In: Reproductive health and research. 4th edn. Geneva: WHO; 2009
   Google Scholar
• Mueller L. Predictability of exogenous hormone effect on subgroups of migraineurs. Headache 2000;40:189–93
   PubMed Web of Science ®Google Scholar
• Aegidius KL, Zwart JA, Hagen K, Schei B, Stovner LJ. Hormone replacement therapy and headache prevalence in postmenopausal women. The Head-HUNT study. Eur J Neurol 2007;14:73–8
   PubMed Web of Science ®Google Scholar
• Nappi RE, Cagnacci A, Granella F, Piccinini F, Polatti F, Facchinetti F. Course of primary headaches during hormone replacement therapy. Maturitas 2001;38:157–63
   PubMed Web of Science ®Google Scholar
• Facchinetti F, Nappi RE, Tirelli A, Polatti F, Nappi G, Sances G. Hormone supplementation differently affects migraine in postmenopausal women. Headache 2002;42:924–9
   PubMed Web of Science ®Google Scholar
• Vestergaard P, Hermann AP, Gram J, et al. Improving compliance with hormonal replacement therapy in primary osteoporosis prevention. Maturitas 1997;28:137–45
   PubMed Web of Science ®Google Scholar
• Minet ML, Valade D, Geraud G, Lucas C, Donnet A. Revised French guidelines for the diagnosis and management of migraine in adults and children. J Headache Pain 2014;15:2
   PubMed Web of Science ®Google Scholar
• Macgregor EA. Estrogen replacement and migraine. Maturitas 2009;63:51–5
   PubMed Web of Science ®Google Scholar
• Lay CL, Broner SW. Migraine in women. Neurol Clin 2009;27:503–11
   PubMed Web of Science ®Google Scholar
• Canonico M, Carcaillon L, Plu-Bureau G, et al. Postmenopausal hormone therapy and risk of stroke impact of the route of estrogen administration and type of progestogen. Stroke 2016;47:1734–41
   PubMed Web of Science ®Google Scholar
• Løkkegaard E, Nielsen LH, Keiding N. Risk of stroke with various types. Of Menopausal Hormone Therapies a National Cohort Study Stroke 2017;48:2266–9
   Google Scholar
• Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2015;100:3975–4011
   PubMed Web of Science ®Google Scholar
• Nappi RE, Sances G, Sommacal A, et al. Different effects of tibolone and low-dose EPT in the management of postmenopausal women with primary headaches. Menopause 2006;13:818–25
   PubMed Web of Science ®Google Scholar
• Cummings RS, Ettinger B, Delmas PD, LIFT Trial Investigators, et al. The effects of tibolone in older postmenopausal women. N Engl J Med 2008;359:697–708
   PubMed Web of Science ®Google Scholar
• Hitchcock CL, Prior JC. Oral micronized progesterone for vasomotor symptoms–a placebo-controlled randomized trial in healthy postmenopausal women. Menopause 2012;19:886–93
   PubMed Web of Science ®Google Scholar
• Caufriez A, Leproult R, L'Hermite-Balériaux M, Kerkhofs M, Copinschi G. Progesterone prevents sleep disturbances and modulates GH, TSH, and melatonin secretion in postmenopausal women. J Clin Endocrinol Metab 2011;96:E614–23
   PubMed Web of Science ®Google Scholar
• Gruber CJ, Huber JC. Differential effects of progestins on the brain. Maturitas 2003;46(Suppl 1):S71–S75
   PubMed Web of Science ®Google Scholar